Clinical Trials Directory

Trials / Completed

CompletedNCT01859650

Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients

Lung HeXeRT: Advanced Proton, Hyperpolarised 3-helium and 129-xenon Magnetic Resonance Imaging for Lung Cancer Radiotherapy Planning and Evaluation

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The University of Sheffield is one of the leading centres in the world for basic and translational research with inhaled gas MRI, which provides lung images with unprecedented spatial and temporal resolution. Our previous work demonstrated that inhaled gas MRI can provide significant clinical information for lung cancer radiotherapy planning and post-treatment evaluation. Building upon this unique experience, a multidisciplinary team will conduct an inhaled gas and proton lung MRI study that will address two of the major clinical problems faced by lung cancer patients treated with radiotherapy. 1. Normal lung tissue is often damaged by the curative radiation dose. The investigators hypothesise that regional ventilation-perfusion lung function imaging with inhaled gas and proton MRI before and after treatment will help to lower the risk of radiation-induced lung injury and help to detect such damage at an early stage. 2. Identification of the extent of cancerous tissue is error-prone when planning treatment from CT images alone. The investigators hypothesise that advanced proton MRI techniques will improve the identification of tumour volume, which is critical to successfully targeting the radiation dose. To achieve these goals, image acquisition and image processing methods will be tested with a study of 20 patients. Results from this study will make an important contribution to improving the treatment of lung disease which is one of the key research priorities of the NHS.

Conditions

Interventions

TypeNameDescription
OTHERMR and CT imaging

Timeline

Start date
2014-12-11
Primary completion
2019-08-08
Completion
2019-08-08
First posted
2013-05-22
Last updated
2019-09-26

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01859650. Inclusion in this directory is not an endorsement.

Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients (NCT01859650) · Clinical Trials Directory